{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T20:59:56Z","timestamp":1762376396286,"version":"3.37.3"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,5,31]],"date-time":"2018-05-31T00:00:00Z","timestamp":1527724800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,5,31]],"date-time":"2018-05-31T00:00:00Z","timestamp":1527724800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004329","name":"Javna Agencija za Raziskovalno Dejavnost RS","doi-asserted-by":"crossref","award":["P1-0230"],"award-info":[{"award-number":["P1-0230"]}],"id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004329","name":"Javna Agencija za Raziskovalno Dejavnost RS","doi-asserted-by":"crossref","award":["J1-8147"],"award-info":[{"award-number":["J1-8147"]}],"id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01-AG025831","AG13308","P50 AG 16570","MH\/ AG58156","MH52453","AG10123"],"award-info":[{"award-number":["P01-AG025831","AG13308","P50 AG 16570","MH\/ AG58156","MH52453","AG10123"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000015","name":"U.S. Department of Energy","doi-asserted-by":"publisher","award":["DE-FC03-87- ER60615"],"award-info":[{"award-number":["DE-FC03-87- ER60615"]}],"id":[{"id":"10.13039\/100000015","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Imaging Biol"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s11307-018-1210-2","type":"journal-article","created":{"date-parts":[[2018,5,31]],"date-time":"2018-05-31T15:48:41Z","timestamp":1527781721000},"page":"25-34","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["The Value of In Vitro Binding as Predictor of In Vivo Results: A Case for [18F]FDDNP PET"],"prefix":"10.1007","volume":"21","author":[{"given":"Graham B.","family":"Cole","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nagichettiar","family":"Satyamurthy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koon-Pong","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary W.","family":"Small","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung-Cheng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janez","family":"Ko\u0161mrlj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge R.","family":"Barrio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5294-9902","authenticated-orcid":false,"given":"Andrej","family":"Petri\u010d","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,5,31]]},"reference":[{"key":"1210_CR1","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1037\/h0040957","volume":"52","author":"LJ Chronback","year":"1955","unstructured":"Chronback LJ, Meehl PE (1955) Construct validity in psychological tests. Psychol Bull 52:281\u2013302","journal-title":"Psychol Bull"},{"key":"1210_CR2","doi-asserted-by":"publisher","first-page":"6222","DOI":"10.1073\/pnas.0914904107","volume":"107","author":"GB Cole","year":"2010","unstructured":"Cole GB, Keum G, Liu J, Small GW, Satyamurthy N, Kepe V, Barrio JR (2010) Specific estrogen sulfotransferase (SULT1E1) substrates and molecular imaging probe candidates. Proc Natl Acad Sci U S A 107:6222\u20136227","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1210_CR3","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1111\/j.1471-4159.2009.05996.x","volume":"109","author":"PW Thompson","year":"2009","unstructured":"Thompson PW, Ye L, Morgenstern JL, Sue L, Beach TG, Judd DJ, Shipley NJ, Libri V, Lockhart A (2009) Interaction of the amyloid imaging tracer FDDNP with hallmark Alzheimer\u2019s disease pathologies. J Neurochem 109:623\u2013630","journal-title":"J Neurochem"},{"issue":"30","key":"1210_CR4","doi-asserted-by":"publisher","first-page":"2607","DOI":"10.1093\/brain\/awm191","volume":"1","author":"A Lockhart","year":"2007","unstructured":"Lockhart A, Lamb JR, Osredkar T et al (2007) PIB is a non-specific imaging marker of amyloid-beta (A\u03b2) peptide-related cerebral amyloidosis. Brain 1(30):2607\u20132615","journal-title":"Brain"},{"key":"1210_CR5","doi-asserted-by":"publisher","first-page":"23599","DOI":"10.1074\/jbc.M501285200","volume":"280","author":"L Ye","year":"2005","unstructured":"Ye L, Morgenstern JL, Gee AD, Hong G, Brown J, Lockhart A (2005) Delineation of positron emission tomography imaging agent binding sites on \u03b2-amyloid peptide fibrils. J Biol Chem 280:23599\u201323604","journal-title":"J Biol Chem"},{"key":"1210_CR6","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.21-24-j0004.2001","volume":"21","author":"ED Agdeppa","year":"2001","unstructured":"Agdeppa ED, Kepe V, Liu J, Flores-Torres S, Satyamurthy N, Petric A, Cole GM, Small GW, Huang SC, Barrio JR (2001) Binding characteristics of radiofluorinated 6-dialkylamino-2-naphthylethylidene derivatives as positron emission tomography imaging probes for \u03b2-amyloid plaques in Alzheimer\u2019s disease. J Neurosci 21:RC189","journal-title":"J Neurosci"},{"key":"1210_CR7","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/S0306-4522(02)00907-7","volume":"117","author":"ED Agdeppa","year":"2003","unstructured":"Agdeppa ED, Kepe V, Petric A et al (2003) In vivo detection of (S)-naproxen and ibuprofen binding to plaques in the Alzheimer\u2019s brain using the positron emission tomography molecular imaging probe 2-(1-{6-[(2-[18F]fluoroethyl)(methyl)amino]-2-naphthyl}ethylidene)malononitrile. Neuroscience 117:723\u2013730","journal-title":"Neuroscience"},{"key":"1210_CR8","volume-title":"Theory and practice of histological techniques","year":"1990","unstructured":"Bancroft JD, Stevens A (eds) (1990) Theory and practice of histological techniques, 3rd edn. Churchill Livingstone, Edinburgh","edition":"3"},{"key":"1210_CR9","doi-asserted-by":"publisher","first-page":"2652","DOI":"10.1056\/NEJMoa054625","volume":"355","author":"GW Small","year":"2006","unstructured":"Small GW, Kepe V, Ercoli LM, Siddarth P, Bookheimer SY, Miller KJ, Lavretsky H, Burggren AC, Cole GM, Vinters HV, Thompson PM, Huang SC, Satyamurthy N, Phelps ME, Barrio JR (2006) PET of brain amyloid and tau in mild cognitive impairment. N Engl J Med 355:2652\u20132663","journal-title":"N Engl J Med"},{"key":"1210_CR10","doi-asserted-by":"publisher","first-page":"145","DOI":"10.3233\/JAD-130032","volume":"36","author":"V Kepe","year":"2013","unstructured":"Kepe V, Bordelon Y, Boxer A, Huang SC, Liu J, Thiede FC, Mazziotta JC, Mendez MF, Donoghue N, Small GW, Barrio JR (2013) PET imaging of neuropathology in tauopathies: progressive supranuclear palsy. J Alzheimers Dis 36:145\u2013153","journal-title":"J Alzheimers Dis"},{"key":"1210_CR11","doi-asserted-by":"publisher","first-page":"261","DOI":"10.3233\/JAD-122434","volume":"36","author":"LM Smid","year":"2013","unstructured":"Smid LM, Kepe V, Vinters HV, Bresjanac M, Toyokuni T, Satyamurthy N, Wong KP, Huang SC, Silverman DH, Miller K, Small GW, Barrio JR (2013) Postmortem 3-D brain hemisphere cortical tau and amyloid-\u03b2 pathology mapping and quantification as a validation method of neuropathology imaging. J Alzheimers Dis 36:261\u2013274","journal-title":"J Alzheimers Dis"},{"key":"1210_CR12","doi-asserted-by":"publisher","first-page":"E2039","DOI":"10.1073\/pnas.1409952112","volume":"112","author":"JR Barrio","year":"2015","unstructured":"Barrio JR, Small GW, Wong KP, Huang SC, Liu J, Merrill DA, Giza CC, Fitzsimmons RP, Omalu B, Bailes J, Kepe V (2015) In vivo characterization of chronic traumatic encephalopathy (CTE) using [F-18]FDDNP-PET brain imaging. Proc Natl Acad Sci USA 112:E2039\u2013E2047","journal-title":"Proc Natl Acad Sci USA"},{"key":"1210_CR13","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1002\/ana.20009","volume":"55","author":"WE Klunk","year":"2004","unstructured":"Klunk WE, Engler H, Nordberg A, Wang Y, Blomqvist G, Holt DP, Bergstr\u00f6m M, Savitcheva I, Huang GF, Estrada S, Aus\u00e9n B, Debnath ML, Barletta J, Price JC, Sandell J, Lopresti BJ, Wall A, Koivisto P, Antoni G, Mathis CA, L\u00e5ngstr\u00f6m B (2004) Imaging brain amyloid in Alzheimer\u2019s disease with Pittsburgh compound-B. Ann Neurol 55:306\u2013319","journal-title":"Ann Neurol"},{"key":"1210_CR14","first-page":"584","volume":"12","author":"NPLG Verhoeff","year":"2004","unstructured":"Verhoeff NPLG, Wilson AA, Takeshita S, Trop L, Hussey D, Singh K, Kung HF, Kung MP, Houle S (2004) In-vivo imaging of Alzheimer\u2019s disease \u03b2-amyloid with [11C]SB-13 PET. Am J Geriatr Psychiatry 12:584\u2013595","journal-title":"Am J Geriatr Psychiatry"},{"key":"1210_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jlcr.2590020102","volume":"2","author":"RJ Bayly","year":"1966","unstructured":"Bayly RJ, Evans EA (1966) Stability and storage of compounds labelled with radioisotopes. J Label Compd 2:1\u201334","journal-title":"J Label Compd"},{"key":"1210_CR16","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s11307-006-0061-4","volume":"9","author":"J Liu","year":"2007","unstructured":"Liu J, Kepe V, \u017dabjek A, Petri\u010d A, Padgett HC, Satyamurthy N, Barrio JR (2007) High-yield, automated radiosynthesis of 2-(1-{6-[(2-[18F]fluoroethyl)(methyl)amino]-2-naphthyl}ethylidene)malononitrile ([18F]FDDNP) ready for animal or human administration. Mol Imaging Biol 9:6\u201316","journal-title":"Mol Imaging Biol"},{"key":"1210_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/(SICI)1098-1063(1999)9:1<1::AID-HIPO1>3.0.CO;2-T","volume":"9","author":"DG Amaral","year":"1999","unstructured":"Amaral DG (1999) Introduction: what is where in the medial temporal lobe? Hippocampus 9:1\u20136","journal-title":"Hippocampus"},{"key":"1210_CR18","doi-asserted-by":"publisher","DOI":"10.1002\/9780470743447","volume-title":"Preparation of compounds labeled with tritium and Carbon-14","author":"R Voges","year":"2009","unstructured":"Voges R, Heys JR, Moenius T (2009) Preparation of compounds labeled with tritium and Carbon-14. Wiley, Chichester"},{"key":"1210_CR19","first-page":"211","volume":"42","author":"SE Tkachenko","year":"2000","unstructured":"Tkachenko SE, Karpov NA, Fedoseev VM (2000) Autoradiolysis of labeled organic compounds. Radiochemistry 42:211\u2013227","journal-title":"Radiochemistry"},{"key":"1210_CR20","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/218472a0","volume":"218","author":"WR Waterfield","year":"1968","unstructured":"Waterfield WR, Spanner JA, Stanford FG (1968) Tritium exchange from compounds in dilute aqueous solutions. Nature 218:472\u2013473","journal-title":"Nature"},{"key":"1210_CR21","doi-asserted-by":"publisher","first-page":"5572","DOI":"10.1021\/ja9543356","volume":"118","author":"A Jacobson","year":"1996","unstructured":"Jacobson A, Petri\u010d A, Hogenkamp D et al (1996) 1,1-Dicyano-2-[6-(dimethylamino)naphthalene-2-yl]propene (DDNP): a solvent polarity and viscosity sensitive fluorophore for fluorescence microscopy. J Am Chem Soc 118:5572\u20135579","journal-title":"J Am Chem Soc"},{"key":"1210_CR22","doi-asserted-by":"publisher","first-page":"16492","DOI":"10.1073\/pnas.1214134109","volume":"109","author":"A Petric","year":"2012","unstructured":"Petric A, Johnson SA, Pham HV, Li Y, Ceh S, Golobic A, Agdeppa ED, Timbol G, Liu J, Keum G, Satyamurthy N, Kepe V, Houk KN, Barrio JR (2012) Dicyanovinylnaphthalenes for neuroimaging of amyloids and relationships of electronic structures and geometries to binding affinities. Proc Natl Acad Sci U S A 109:16492\u201316497","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1210_CR23","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.brainres.2004.08.004","volume":"1025","author":"MP Kung","year":"2004","unstructured":"Kung MP, Hou C, Zhuang ZP, Skovronsky D, Kung HF (2004) Binding of two potential imaging agents targeting amyloid plaques in postmortem brain tissues of patients with Alzheimer\u2019s disease. Brain Res 1025:98\u2013105","journal-title":"Brain Res"},{"key":"1210_CR24","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1038\/sj.jcbfm.9600146","volume":"25","author":"JC Price","year":"2005","unstructured":"Price JC, Klunk WE, Lopresti BJ, Lu X, Hoge JA, Ziolko SK, Holt DP, Meltzer CC, DeKosky ST, Mathis CA (2005) Kinetic modeling of amyloid binding in humans using PET imaging and Pittsburgh compound-B. J Cereb Blood Flow Metab 25:1528\u20131547","journal-title":"J Cereb Blood Flow Metab"},{"key":"1210_CR25","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1097\/00004647-199609000-00008","volume":"16","author":"J Logan","year":"1996","unstructured":"Logan J, Fowler JS, Volkow ND, Wang GJ, Ding YS, Alexoff DL (1996) Distribution volume ratios without blood sampling from graphical analysis of PET data. J Cereb Blood Flow Metab 16:834\u2013840","journal-title":"J Cereb Blood Flow Metab"},{"key":"1210_CR26","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/S0969-8051(00)00137-2","volume":"27","author":"J Logan","year":"2000","unstructured":"Logan J (2000) Graphical analysis of PET data applied to reversible and irreversible tracers. Nucl Med Biol 27:661\u2013670","journal-title":"Nucl Med Biol"},{"key":"1210_CR27","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.nucmedbio.2005.02.003","volume":"32","author":"K Shogi-Jadid","year":"2005","unstructured":"Shogi-Jadid K, Barrio JR, Kepe V et al (2005) Imaging \u03b2-amyloid fibrils in Alzheimer\u2019s disease: a critical analysis through simulation of amyloid fibril polymerization. Nucl Med Biol 32:337\u2013351","journal-title":"Nucl Med Biol"},{"key":"1210_CR28","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s11307-006-0037-4","volume":"8","author":"K Shogi-Jadid","year":"2006","unstructured":"Shogi-Jadid K, Barrio JR, Kepe V et al (2006) Exploring a mathematical model for the kinetics of \u03b2-amyloid molecular imaging probes through a critical analysis of plaque pathology. Mol Imaging Biol 8:151\u2013162","journal-title":"Mol Imaging Biol"},{"key":"1210_CR29","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.jalz.2012.11.008","volume":"9","author":"CF Xia","year":"2013","unstructured":"Xia CF, Arteaga J, Chen G, Gangadharmath U, Gomez LF, Kasi D, Lam C, Liang Q, Liu C, Mocharla VP, Mu F, Sinha A, Su H, Szardenings AK, Walsh JC, Wang E, Yu C, Zhang W, Zhao T, Kolb HC (2013) [18F]T807, a novel tau positron emission tomography imaging agent for Alzheimer\u2019s disease. Alzheimers Dement 9:666\u2013676","journal-title":"Alzheimers Dement"},{"key":"1210_CR30","doi-asserted-by":"publisher","first-page":"P283","DOI":"10.1016\/j.jalz.2015.07.381","volume":"11","author":"C Vermeiren","year":"2015","unstructured":"Vermeiren C, Mercier J, Viot D, Mairet-Coello G, Hannestad J, Courade JP, Citron M, Gillard M (2015) T807, a reported selective tau tracer, binds with nanomolar affinity to monoamine oxidase a. Alzheimer\u2019s Dement Suppl 11:P283","journal-title":"Alzheimer\u2019s Dement Suppl"},{"key":"1210_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2014.91","volume":"4","author":"EM Mitsis","year":"2014","unstructured":"Mitsis EM, Riggio S, Kostakoglu L, Dickstein DL, Machac J, Delman B, Goldstein M, Jennings D, D\u2019Antonio E, Martin J, Naidich TP, Aloysi A, Fernandez C, Seibyl J, DeKosky ST, Elder GA, Marek K, Gordon W, Hof PR, Sano M, Gandy S (2014) Tauopathy PET and amyloid PET in the diagnosis of chronic traumatic encephalopathies: studies of a retired NFL player and of a man with FTD and a severe head injury. Transl Psychiatry 4:e441","journal-title":"Transl Psychiatry"},{"key":"1210_CR32","doi-asserted-by":"publisher","first-page":"229","DOI":"10.12688\/f1000research.5372.1","volume":"3","author":"S Gandy","year":"2014","unstructured":"Gandy S, DeKosky ST (2014) [18F]-T807 tauopathy PET imaging in chronic traumatic encephalopathy. F1000 Res 3:229","journal-title":"F1000 Res"},{"key":"1210_CR33","doi-asserted-by":"publisher","first-page":"115","DOI":"10.2967\/jnumed.117.198960","volume":"59","author":"JR Barrio","year":"2018","unstructured":"Barrio JR (2018) The irony of PET tau probe specificity. J Nucl Med 59:115\u2013116","journal-title":"J Nucl Med"},{"key":"1210_CR34","first-page":"1.4.1","volume-title":"Neuroanatomical methods receptor binding techniques. Current protocols in neuroscience","author":"KA Frey","year":"1997","unstructured":"Frey KA, Albin RL (1997) Neuroanatomical methods receptor binding techniques. Current protocols in neuroscience. Wiley, New York, pp 1.4.1\u20131.4.14"},{"key":"1210_CR35","first-page":"270","volume-title":"PET\u2014molecular imaging and its biological applications","author":"JR Barrio","year":"2004","unstructured":"Barrio JR (2004) The molecular basis of disease. In: Phelps ME (ed) PET\u2014molecular imaging and its biological applications. Springer, New York, pp 270\u2013320"},{"key":"1210_CR36","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.pathophys.2009.07.001","volume":"17","author":"O Hallberg","year":"2009","unstructured":"Hallberg O, Johansson O (2009) Sleep on the right side\u2014get cancer on the left? Pathophysiology 17:157\u2013160","journal-title":"Pathophysiology"},{"key":"1210_CR37","first-page":"1","volume":"21","author":"O Hallberg","year":"2002","unstructured":"Hallberg O, Johansson O (2002) Cancer trends during the 20th century. ACNEM 21:1\u20136","journal-title":"ACNEM"},{"key":"1210_CR38","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/20094","volume":"399","author":"GE Quinn","year":"1999","unstructured":"Quinn GE, Shin CH, Maguire MG, Stone RA (1999) Myopia and ambient lighting at night. Nature 399:113\u2013114","journal-title":"Nature"},{"key":"1210_CR39","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/S0140-6736(97)11096-0","volume":"351","author":"AJ Wakefield","year":"1998","unstructured":"Wakefield AJ, Murch SH, Anthony A et al (1998) Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet 351:637\u2013641 Retracted in 2010","journal-title":"Lancet"},{"key":"1210_CR40","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.mibio.2003.09.010","volume":"5","author":"ED Agdeppa","year":"2003","unstructured":"Agdeppa ED, Kepe V, Shoghi-Jadid K et al (2003) 2-Dialkylamino-6-acylmalononitrile substituted naphthalenes (DDNP analogs): novel diagnostic and therapeutic tools in Alzheimer\u2019s disease. Mol Imaging Biol 5:407\u2013417","journal-title":"Mol Imaging Biol"}],"container-title":["Molecular Imaging and Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11307-018-1210-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11307-018-1210-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11307-018-1210-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T21:17:49Z","timestamp":1589663869000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11307-018-1210-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,31]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["1210"],"URL":"https:\/\/doi.org\/10.1007\/s11307-018-1210-2","relation":{},"ISSN":["1536-1632","1860-2002"],"issn-type":[{"type":"print","value":"1536-1632"},{"type":"electronic","value":"1860-2002"}],"subject":[],"published":{"date-parts":[[2018,5,31]]},"assertion":[{"value":"31 May 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The University of California, Los Angeles, owns a U.S. patent (6,274,119) entitled \u201cMethods for Labeling \u03b2-Amyloid Plaques and Neurofibrillary Tangles,\u201d which has been licensed to TauMark, LLC. N.S., G.W.S., S.-C.H., A.P., and J.R.B. are among the inventors. N.S., S.-C.H., G.W.S., and J.R.B. have equity interest in TauMark, LLC. All other authors report no financial conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}